Clinical Trial

A Study of HS-10518 in Healthy Adult Premenopausal Females in China

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HS-10518 in healthy adult premenopausal females in China
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-23.
Trial Details
NCT Number NCT07264192
Lead Sponsor West China Second University Hospital
Collaborators: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions Infertility, Female
Enrollment 60 participants
Start Date 2025-03-11
Primary Completion 2025-06-23 (estimated)
Study Completion 2025-09-09 (estimated)
Updated on ClinicalTrials.gov 2026-03-25